These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 8209099
1. Stimulation of phagocytosis against Staphylococcus aureus by teicoplanin and vancomycin. Pedrera MI, Pérez F, Rodríguez AB, Barriga C. Rev Esp Fisiol; 1993 Dec; 49(4):231-4. PubMed ID: 8209099 [Abstract] [Full Text] [Related]
2. Comparative study of the effect of teicoplanin and vancomycin upon the phagocytic process of peritoneal macrophages. Barriga C, Pedrera I, Rodríguez AB. Rev Esp Fisiol; 1996 Dec; 52(4):215-22. PubMed ID: 9144842 [Abstract] [Full Text] [Related]
3. Intracellular activity of both teicoplanin and vancomycin against Staphylococcus aureus in human neutrophils. Pedrera MI, Barriga C, Rodriguez AB. Comp Immunol Microbiol Infect Dis; 1995 Feb; 18(2):123-8. PubMed ID: 7621668 [Abstract] [Full Text] [Related]
4. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999]. Nashev D, Toshkova K, Gavrilova V. Vutr Boles; 2000 Feb; 32(2):35-40. PubMed ID: 11227664 [Abstract] [Full Text] [Related]
5. The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms. Fietta A, Bersani C, De Rose V, Grassi FM, Gialdroni Grassi G. J Hosp Infect; 1986 Mar; 7 Suppl A():57-63. PubMed ID: 2871098 [Abstract] [Full Text] [Related]
6. Influence of teicoplanin on the chemiluminescence of phagocytosing human granulocytes. Aquilini D, Bartoloni A, Paradisi F. J Chemother; 1991 Jan; 3 Suppl 1():119-21. PubMed ID: 12041744 [Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [Abstract] [Full Text] [Related]
8. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Kuti JL, Kiffer CR, Mendes CM, Nicolau DP. Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672 [Abstract] [Full Text] [Related]
9. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin]. Gil M, Otth L, Wilson M, Arce E, Zaror A, Lizama V. Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531 [No Abstract] [Full Text] [Related]
10. [Heterogeneity of Brain Heart Infusion agar media (BHI): effects on the determination of the vancomycin and the teicoplanin minimal inhibitory concentrations (MIC) of Staphylococcus aureus strains]. Martin C. Pathol Biol (Paris); 2004 Oct; 52(8):450-4. PubMed ID: 15465263 [Abstract] [Full Text] [Related]
11. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. Samra Z, Ofer O, Shmuely H. Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257 [Abstract] [Full Text] [Related]
12. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains. Bernard L, Vaudaux P, Rohner P, Huggler E, Armanet M, Pittet D, Lew DP, Schrenzel J. J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063 [Abstract] [Full Text] [Related]
13. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods. Goldstein FW, Atoui R, Ben Ali A, Nguyen JC, Ly A, Kitzis MD. Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127 [Abstract] [Full Text] [Related]
14. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model. Atahan E, Gul M, Ergun Y, Eroglu E. Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929 [Abstract] [Full Text] [Related]
15. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units. Kucukates E, Nalan Karayel E, Gultekin N, Okuyan E, Kansiz E, Gurler N. Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323 [No Abstract] [Full Text] [Related]
16. Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system. Bowker KE, Noel AR, MacGowan AP. J Antimicrob Chemother; 2006 Oct; 58(4):802-5. PubMed ID: 16891629 [Abstract] [Full Text] [Related]
17. The influence of human monocytes on the antibacterial activity of vancomycin and teicoplanin against Staphylococcus aureus. van der Broek PJ, Buys LF. J Antimicrob Chemother; 1990 May; 25(5):787-95. PubMed ID: 2142684 [Abstract] [Full Text] [Related]
18. Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin. Onyeji CO, Nightingale CH, Marangos MN. Infection; 1994 May; 22(5):338-42. PubMed ID: 7843812 [Abstract] [Full Text] [Related]
19. In vitro activity of vancomycin and teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis colonizing catheters. Kropec A, Huebner J, Wursthorn M, Daschner FD. Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):545-8. PubMed ID: 8404917 [Abstract] [Full Text] [Related]
20. Selection of resistance to glycopeptide antibiotics in staphylococci. Biavasco F, Giovanetti E, Varaldo PE. J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]